A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD - Archive ouverte HAL
Article Dans Une Revue Blood Année : 2017

A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD

Domaines

Hématologie

Dates et versions

hal-01655868 , version 1 (05-12-2017)

Identifiants

Citer

Gérard Socié, Stéphane Vigouroux, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Furst, et al.. A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD. Blood, 2017, 129 (5), pp.643 - 649. ⟨10.1182/blood-2016-09-738625⟩. ⟨hal-01655868⟩
69 Consultations
0 Téléchargements

Altmetric

Partager

More